Verano Holdings (VRNO) Inventory Average (2022 - 2026)
Verano Holdings (VRNO) posted quarterly Inventory Average of $232.8 million for Q1 2026, up 23.58% year-over-year from $188.4 million in Q1 2025, and up 3.53% quarter-over-quarter from $224.8 million in Q4 2025.
Verano Holdings (VRNO) Inventory Average (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Inventory Average for 5 consecutive years, with $232.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 23.58% year-over-year to $232.8 million; the TTM figure through Mar 2026 stood at $232.8 million (up 23.58% YoY), while the FY2025 annual figure was $207.2 million, up 21.81% from the prior year.
- Inventory Average climbed to $232.8 million in Q1 2026 per VRNO's latest filing, from $224.8 million in the prior quarter.
- Across five years, Inventory Average topped out at $232.8 million in Q1 2026 and bottomed at $3.5 million in Q1 2022.
- Historically, Inventory Average has averaged $163.8 million across 5 years, with a median of $166.3 million in 2022.
- On a YoY basis, Inventory Average climbed as much as 4466.37% in 2023 and fell as far as 8.22% in 2023.
- Verano Holdings' Inventory Average stood at $166.3 million in 2022, then retreated by 7.84% to $153.3 million in 2023, then advanced by 23.46% to $189.3 million in 2024, then grew by 18.81% to $224.8 million in 2025, then grew by 3.53% to $232.8 million in 2026.
- Business Quant data shows VRNO's Inventory Average at $232.8 million in Q1 2026, $224.8 million in Q4 2025, and $217.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Verano Holdings | 438.82 Mn | 353.62 Mn | 99.70 Mn | 228.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 228.89 Mn |
| Mar 31, 2026 | 232.77 Mn |
| Dec 31, 2025 | 224.84 Mn |
| Sep 30, 2025 | 217.03 Mn |
| Jun 30, 2025 | 203.30 Mn |
| Mar 31, 2025 | 188.36 Mn |
| Dec 31, 2024 | 189.25 Mn |
| Sep 30, 2024 | 181.70 Mn |
| Jun 30, 2024 | 167.77 Mn |
| Mar 31, 2024 | 160.97 Mn |
| Dec 31, 2023 | 153.29 Mn |
| Sep 30, 2023 | 147.85 Mn |
| Jun 30, 2023 | 149.25 Mn |
| Mar 31, 2023 | 159.07 Mn |
| Dec 31, 2022 | 166.34 Mn |
| Sep 30, 2022 | 161.10 Mn |
| Jun 30, 2022 | 78.97 Mn |
| Mar 31, 2022 | 3.48 Mn |